Nutex Health, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Nutex Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q1 2024.
  • Nutex Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$95.4K, a 89.5% increase year-over-year.
  • Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$5.71M, a 214% decline from 2022.
  • Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $5M.
  • Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$985K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$95.4K +$815K +89.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$911K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.